Publications

Isolation and Potential for Transmission of Mycobacterium bovis at Human-livestock-wildlife Interface of the Serengeti Ecosystem, Northern Tanzania.

Katale, BZ; Mbugi, EV; Siame, KK; Keyyu, JD; Kendall, S; Kazwala, RR; DOCKRELL, HM; Fyumagwa, RD; Michel, AL; Rweyemamu, M; Streicher, EM; Warren, RM; Van Helden, P; Matee, MI;

2015

Transboundary and emerging diseases, (2015).64 3 10.1111/tbed.12445.

Risk of tuberculosis in patients with diabetes: population based cohort study using the UK Clinical Practice Research Datalink.

PEALING, L; WING, K; MATHUR, R; PRIETO-MERINO, D; SMEETH, L; MOORE, DA J;

2015

BMC medicine, (2015).13 1 10.1186/s12916-015-0381-9.

Robust and Reproducible Quantification of the Extent of Chest Radiographic Abnormalities (And It's Free!).

Requena-Méndez, A; Aldasoro, E; Muñoz, J; MOORE, DA J;

2015

PloS one, (2015).10 5 10.1371/journal.pone.0128044.

Individual-level factors associated with variation in mycobacterial-specific immune response: Gender and previous BCG vaccination status.

RHODES, SJ; KNIGHT, GM; FIELDING, K; Scriba, TJ; Pathan, AA; McShane, H; FLETCHER, H; WHITE, RG;

2015

Tuberculosis (Edinburgh, Scotland), (2015).96, 10.1016/j.tube.2015.10.002.

Differential transcriptomic and metabolic profiles of M. africanum- and M. tuberculosis-infected patients after, but not before, drug treatment.

TIENTCHEU, LD; Maertzdorf, J; Weiner, J; ADETIFA, IM; Mollenkopf, H-J; SUTHERLAND, JS; Donkor, S; KAMPMANN, B; Kaufmann, SH E; DOCKRELL, HM; Ota, MO;

2015

Genes and immunity, (2015).16 5 10.1038/gene.2015.21.

Good quality locally procured drugs can be as effective as internationally quality assured drugs in treating multi-drug resistant tuberculosis.

Qadeer, E; Fatima, R; FIELDING, K; Qazi, F; MOORE, D; KHAN, MS;

2015

PloS one, (2015).10 4 10.1371/journal.pone.0126099.

Microscopic Observation Drug Susceptibility Assay for Rapid Diagnosis of Lymph Node Tuberculosis and Detection of Drug Resistance.

Kirwan, DE; Ugarte-Gil, C; Gilman, RH; Caviedes, L; Rizvi, H; Ticona, E; Chavez, G; Cabrera, JL; Matos, ED; Evans, CA; MOORE, DA J; Friedland, JS; Lymph Node TB Working Group, Peru,;

2015

Journal of clinical microbiology, (2015).54 1 10.1128/JCM.02227-15.

The draft genome of Mycobacterium aurum, a potential model organism for investigating drugs against Mycobacterium tuberculosis and Mycobacterium leprae.

PHELAN, J; Maitra, A; McNerney, R; Nair, M; GUPTA, A; COLL, F; Pain, A; Bhakta, S; CLARK, TG;

2015

International journal of mycobacteriology, (2015).4 3 10.1016/j.ijmyco.2015.05.001.

Systematic analysis of funding awarded to institutions in the United Kingdom for infectious disease research, 1997-2010.

Head, MG; FITCHETT, JR; MOORE, DA; Atun, R;

2015

JRSM open, (2015).6 3 10.1177/2054270415577056.

Effect of isoniazid preventive therapy on immune responses to mycobacterium tuberculosis: an open label randomised, controlled, exploratory study.

Biraro, IA; EGESA, M; Kimuda, S; SMITH, SG; TOULZA, F; Levin, J; Joloba, M; Katamba, A; COSE, S; DOCKRELL, HM; ELLIOTT, AM;

2015

BMC infectious diseases, (2015).15 1 10.1186/s12879-015-1201-8.